title: Immune Responses to Novel Adenovirus Type 26 and Modified Vaccinia Virus Ankara-Vectored Ebola Vaccines at 1 Year.
authors.affiliation: Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
authors.forename: Rebecca L
authors.initials: RL
authors.lastname: Winslow
authors.affiliation: Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
authors.forename: Iain D
authors.initials: ID
authors.lastname: Milligan
authors.affiliation: Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
authors.forename: Merryn
authors.initials: M
authors.lastname: Voysey
authors.affiliation: Janssen, Leiden, the Netherlands.
authors.forename: Kerstin
authors.initials: K
authors.lastname: Luhn
authors.affiliation: Janssen, Leiden, the Netherlands.
authors.forename: Georgi
authors.initials: G
authors.lastname: Shukarev
authors.affiliation: Janssen, Leiden, the Netherlands.
authors.forename: Macaya
authors.initials: M
authors.lastname: Douoguih
authors.affiliation: Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
authors.forename: Matthew D
authors.initials: MD
authors.lastname: Snape
mesh_terms: D000256:Adenoviridae / Q000276:immunology*; D000328:Adult; D000914:Antibodies, Viral / Q000097:blood; D046129:Ebola Vaccines / Q000276:immunology*; D005260:Female; D005500:Follow-Up Studies; D006023:Glycoproteins; D019142:Hemorrhagic Fever, Ebola / Q000276:immunology* / Q000517:prevention & control; D006801:Humans; D007111:Immunity, Cellular; D007115:Immunization Schedule; D007117:Immunization, Secondary; D008297:Male; D016037:Single-Blind Method; D013601:T-Lymphocytes / Q000276:immunology; D013997:Time Factors; D014616:Vaccinia virus / Q000276:immunology*; D014764:Viral Proteins / Q000276:immunology
chemical_list: D000914:Antibodies, Viral; D046129:Ebola Vaccines; D006023:Glycoproteins; D014764:Viral Proteins